Recruiting Breast Cancer Studies in Auburn
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-I...
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared ...
Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, ...
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
This is a Phase III, randomized, open-label multicenter study that will evaluate the efficacy and safety of giredestrant compared with fulvestrant, both in combination with the investigator's choice o...
About Breast Cancer Clinical Trials in Auburn
Breast cancer is a disease in which cells in the breast grow out of control. It is the most common cancer in women worldwide and can also occur in men. Treatment options include surgery, radiation, chemotherapy, hormone therapy, and targeted therapies.
There are currently 4 breast cancer clinical trials recruiting participants in Auburn, CA. These studies are seeking a combined 7,700 participants. Research is being sponsored by National Cancer Institute (NCI), NRG Oncology, Hoffmann-La Roche. Clinical trial participation is free and participants receive study-related medical care at no cost.
Breast Cancer Clinical Trials in Auburn — FAQ
Are there breast cancer clinical trials in Auburn?
Yes, there are 4 breast cancer clinical trials currently recruiting in Auburn, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Auburn?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Auburn research site will contact you about next steps.
Are clinical trials in Auburn free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Auburn studies also compensate for your time and travel.
What breast cancer treatments are being tested?
The 4 active trials in Auburn are testing new therapies including novel drugs, biologics, and treatment approaches for breast cancer.
Data updated March 2, 2026 from ClinicalTrials.gov